LATEST NEWS   Spending adjustments will be made without affecting critical services to the people and economic stability - MoF | Guidelines have been issued to ministries and agencies to reorganise the priorities of operating expenditures in line with the challenges posed by the global supply crisis and the increase in subsidy burdens - MoF | Call for the return of three Malaysian elephants from Japan should be given serious consideration - Arthur | MTEN continually monitors and is attentive about global prices for the supply of crude oil, products for RON95 and diesel - Fahmi | MoF studying more targeted mechanism similar to BUDI95 for diesel subsidy implementation in Sabah and Sarawak -- Fahmi | 

There are 67 news based on search keyword " medicine"

Bioeconomy Corporation Targets RM2.2 Bln Revenue In 2026

PUTRAJAYA, Jan 7 (Bernama) — Bioeconomy Corporation aims to generate at least RM2.2 billion in revenue from companies under its BioNexus Status and Bio-based Accelerator (BBA) programmes in 2026, said chief executive officer Mohd Khairul Fidzal Abdul Razak. 

RM73.81 Mln In Excise Duty On Sugar-Sweetened Beverages Collected From Jan To Nov 2025 - MoF

KUALA LUMPUR, Nov 24 (Bernama) -- The government collected RM73.81 million in excise duty on sugar-sweetened beverages (SSBs) from January to November 2025, bringing total SSB excise revenue to RM521.35 million to date, according to the Ministry of Finance (MoF).

Fiscal Discipline Has Enabled Ringgit To Be Top Performer Among Asian Currencies - PM Anwar

KUALA LUMPUR, Nov 18 (Bernama) -- Fiscal discipline and systematic management of the national economy have enabled the ringgit to record the best performance in all of Asia, according to Prime Minister Datuk Seri Anwar Ibrahim.

SBC Medical Partners BLEZ To Bring Japanese-Quality Aesthetic Medicine To Thailand

KUALA LUMPUR, Nov 17 (Bernama) -- SBC Medical Group Holdings Inc has entered a consulting agreement with Thailand-based BLEZ ASIA Co Ltd as part of its strategy to expand into the rapidly growing Thai aesthetic medicine market.

SBC Medical To Acquire Waqoo, Boosting R&D And Clinical Services

KUALA LUMPUR, Nov 14 (Bernama) -- SBC Medical Group Holdings Inc (SBC Medical), a global provider of consulting and management services for medical corporations, announced that its Japanese subsidiary, SBC Medical Group Co Ltd, will launch a tender offer to acquire shares of Waqoo Inc, listed on the Tokyo Stock Exchange Growth Market.

Pharmaceutical Market Poised For Growth Following Malaysia-US Agreement

KUALA LUMPUR, Nov 3 (Bernama) -- The United States (US) pharmaceutical companies are likely to see increased sales in Malaysia following the signing of the Malaysia-US Agreement on Reciprocal Trade (ART).

Curia Invests US$4 Mln To Upgrade API Aseptic Facilities In Spain

KUALA LUMPUR, Oct 30 (Bernama) -- Curia Global Inc, a global research, development and manufacturing organisation, has completed a US$4 million investment to upgrade its two active pharmaceutical ingredient (API) aseptic suites in Valladolid, Spain. (US$1=RM4.18)

US-ASEAN Business Council Strengthens Ties With ASEAN Through Innovation Showcase

KUALA LUMPUR, Oct 28 (Bernama) -- The US-ASEAN Business Council (USABC), in partnership with the ASEAN Committee on Science, Technology and Innovation (COSTI), recently hosted the USABC Innovation Showcase on the sidelines of the 88th COSTI Meeting in Bangkok, Thailand.

Bioeconomy Corporation Targets Over RM300 Million Investment In Sarawak

KUCHING, Oct 23 (Bernama) -- Malaysia Bioeconomy Development Corporation (Bioeconomy Corporation) aims to attract more than RM300 million in potential investments through the National Bioeconomy (NBiO) Showcase, held alongside the Sarawak International Digital Economy Conference (IDEC) 2025 here.

BioInnovation Launchpad 2025 To Propel Bio Entrepreneurs To Global Market

KUALA LUMPUR, Oct 9 (Bernama) -- The BioInnovation Launchpad 2025 programme under BioXceed 2025 is expected to produce at least 10 high-potential bio-entrepreneurs capable of achieving Bio-based Accelerator (BBA) or BioNexus status, further strengthening the national biotechnology ecosystem by 2030.

Nilo Therapeutics Launches With US$101 Mln Series A Financing 

KUALA LUMPUR, Oct 9 (Bernama) -- Nilo Therapeutics, a biotechnology company, emerged from stealth today with a US$101 million Series A financing, aiming to revolutionise immunomodulation by targeting neural circuits that regulate the immune system. (US$1=RM4.21)

Saudi Healthcare Leader Calls For Global Shift: Treat Health As Investment, Not Expense

KUALA LUMPUR, Sept 25 (Bernama) -- Healthcare must be recognised as the world’s most strategic investment in security, prosperity, and resilience—not as a financial burden.